Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient

Videos - Interview with the Innovators
Kate Sasser
Senior Vice President
Head of Translational Research and
R&D Operations
Hisham Hamadeh
Vice President
Global Head of Data Science

Please join Kate Sasser, Senior Vice President, Head of Translational Research and R&D Operations, and Hisham Hamadeh, Vice President and Global Head of Data Science at Genmab, as they discuss how Genmab’s scientists bridge two different but related worlds—translational research and data science—with the hope to deliver the right cancer therapy for the right patient using Genmab’s proprietary antibody platform.

COM-US-General-0000057

Copyright © Engage Healthcare Communications, LLC. All rights reserved.